GERI-BP002-A
Product Specifications
UNSPSC Description
GERI-BP002-A is an inhibitor of acyl-CoA:cholesterol acyltransferase (ACAT) produced by Aspergillus fumigatus F93, which can be used in cancer research[1].
Target Antigen
Acyltransferase
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/geri-bp002-a.html
Purity
97.78
Solubility
10 mM in DMSO
Smiles
OC1=C(C(C)(C)C)C=C(C)C=C1CC2=CC(C)=CC(C(C)(C)C)=C2O
Molecular Weight
340.50
References & Citations
[1]Kim Y K, et al. GERI-BP002-A, novel inhibitor of acyl-CoA: cholesterol acyltransferase produced by Aspergillus fumigatus F93[J]. The Journal of Antibiotics, 1996, 49(1): 31-36.
Shipping Conditions
Room Temperature
Storage Conditions
RT, stored under nitrogen
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-121254/GERI-BP002-A-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-121254/
Badge
Hot
Clinical Information
No Development Reported
CAS Number
119-47-1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6365841-01 0.1 mL
ZNF202, ID (ZNF202, ZKSCAN10, Zinc finger protein 202, Zinc finger protein with KRAB and SCAN domains 10) (MaxLight 750)
Ask
View Details MBS6365841-02 5x 0.1 mL
ZNF202, ID (ZNF202, ZKSCAN10, Zinc finger protein 202, Zinc finger protein with KRAB and SCAN domains 10) (MaxLight 750)
Ask
View Details MBS1095903-01 0.02 mg (E-Coli)
Recombinant Clavibacter michiganensis subsp. sepedonicus Diaminopimelate epimerase (dapF)
Ask
View Details MBS1095903-02 0.02 mg (Yeast)
Recombinant Clavibacter michiganensis subsp. sepedonicus Diaminopimelate epimerase (dapF)
Ask
View Details 
MBS1095903-03 0.1 mg (E-Coli)
Recombinant Clavibacter michiganensis subsp. sepedonicus Diaminopimelate epimerase (dapF)
Ask
View Details 
MBS1095903-04 0.1 mg (Yeast)
Recombinant Clavibacter michiganensis subsp. sepedonicus Diaminopimelate epimerase (dapF)
Ask
View Details